{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:42:23Z","timestamp":1793032943116,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019305","name":"Manipal Academy of Higher Education","doi-asserted-by":"publisher","award":["Dr. T.M.A. Pai Doctoral Fellowship"],"award-info":[{"award-number":["Dr. T.M.A. Pai Doctoral Fellowship"]}],"id":[{"id":"10.13039\/100019305","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100638","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:12:28Z","timestamp":1786547548000},"page":"100638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanisms and therapeutic design of stimuli-responsive vesicular nanocarriers for melanoma"],"prefix":"10.1016","volume":"12","author":[{"given":"Rudresh","family":"Adarkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Dessai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Madanahalli","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamshi Krishna","family":"Tippavajhala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekar Kodangala","family":"Subraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100638_bb0005","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1021\/acs.orglett.5c00747","article-title":"Thioether oxidation chemistry in reactive oxygen species (ROS)-sensitive trigger design: a kinetic analysis","volume":"27","author":"Abdelfattah","year":"2025","journal-title":"Org. Lett."},{"key":"10.1016\/j.ijpx.2026.100638_bb0010","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/0113892010318519240813053106","article-title":"A review on the mechanisms, applications, and clinical trials of advanced technologies in the transdermal drug delivery system","volume":"26","author":"Abdul Aziz","year":"2025","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijpx.2026.100638_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100123","article-title":"Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis","volume":"10","author":"Alam","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.ijpx.2026.100638_bb0025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/polym14050936","article-title":"pH-responsive nanocarriers in cancer therapy","volume":"14","author":"Alsawaftah","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijpx.2026.100638_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejpb.2019.10.011","article-title":"Passive permeability assay of doxorubicin through model cell membranes under cancerous and normal membrane potential conditions","volume":"146","author":"Aminipour","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpx.2026.100638_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101753","article-title":"Adaptive redox homeostasis in cutaneous melanoma","volume":"37","author":"Arslanbaeva","year":"2020","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.ijpx.2026.100638_bb0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nchem.2917","article-title":"Engineered modular biomaterial logic gates for environmentally triggered therapeutic delivery","volume":"10","author":"Badeau","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ijpx.2026.100638_bb0045","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3390\/ijms25063142","article-title":"Targeting the Warburg effect in cancer: where do we stand?","volume":"25","author":"Barba","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0050","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3892\/mco.2014.356","article-title":"Passive targeting of nanoparticles to cancer: a comprehensive review of the literature","volume":"2","author":"Bazak","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0055","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1567201816666190201143457","article-title":"Topical and transdermal drug delivery: from simple potions to smart technologies","volume":"16","author":"Benson","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.colsurfb.2016.03.036","article-title":"Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention","volume":"143","author":"Boakye","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100638_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/pcmr.12495","article-title":"Acidic tumor microenvironment in human melanoma","volume":"29","author":"B\u00f6hme","year":"2016","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.ijpx.2026.100638_bb0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13046-018-0915-z","article-title":"Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules","volume":"37","author":"Boussadia","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ijpx.2026.100638_bb0080","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijpx.2026.100638_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1244","article-title":"Boolean logic in synthetic biology and biomaterials: towards living materials in mammalian cell therapeutics","volume":"13","author":"Bressler","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijpx.2026.100638_bb0090","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/10717544.2020.1797238","article-title":"A pH\/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer","volume":"27","author":"Chang","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0095","article-title":"Global burden of skin cancer and its subtypes: a comprehensive analysis from 1990 to 2021 with projections to 2040","volume":"13","author":"Chen","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ijpx.2026.100638_bb0100","first-page":"155","article-title":"Design and preparation of pH\/temperature stimulated responsive core-shell mesoporous silica nanoparticles[pH\/\u6e29\u5ea6\u523a\u6fc0\u54cd\u5e94\u578b\u6838-\u58f3\u7ed3\u6784\u4ecb\u5b54\u4e8c\u6c27\u5316\u7845\u7eb3\u7c73\u9897\u7c92\u7684\u8bbe\u8ba1\u4e0e\u5236\u5907]","volume":"35","author":"Chen","year":"2022","journal-title":"J. Funct. Polym."},{"key":"10.1016\/j.ijpx.2026.100638_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.actbio.2025.10.035","article-title":"Structure- or size-transformable peptide-based antibacterial biomaterials: design strategies, functions, and applications","volume":"208","author":"Chen","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100638_bb0110","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.3390\/pharmaceutics15112622","article-title":"Advances in polymeric micelles: responsive and targeting approaches for cancer immunotherapy in the tumor microenvironment","volume":"15","author":"Cheng","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100638_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41420-025-02806-0","article-title":"Acidic melanoma microenvironment selects for a senescence-like but also migratory-active subpopulation driving metastatic disease","volume":"11","author":"Chiheb","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ijpx.2026.100638_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.colsurfb.2017.05.007","article-title":"Multi-layered nanogels with MMP-sheddable PEG masks: preparation and promotion of tumor cell uptake by controlling surface characteristics","volume":"156","author":"Choi","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100638_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.855019","article-title":"pH-responsive polymer nanomaterials for tumor therapy","volume":"12","author":"Chu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0130","article-title":"Lipoic acid-boronophenylalanine-derived multifunctional vesicles for cancer chemoradiotherapy","volume":"16","author":"Dai","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100638_bb0135","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/cancers15051417","article-title":"How Warburg-associated lactic acidosis rewires cancer cell energy metabolism to resist glucose deprivation","volume":"15","author":"Daverio","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100638_bb0140","doi-asserted-by":"crossref","first-page":"17733","DOI":"10.1038\/s41598-023-44783-3","article-title":"Warburg-associated acidification represses lactic fermentation independently of lactate, contribution from real-time NMR on cell-free systems","volume":"13","author":"Daverio","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100638_bb0145","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/molecules31020344","article-title":"Nanotechnology in cutaneous oncology: the role of liposomes in targeted melanoma therapy","volume":"31","author":"de Paulo","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100638_bb0150","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(25)00017-8","article-title":"Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysis","volume":"26","author":"Dee","year":"2025","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130396","article-title":"Rational design and translational advancement of phospholipid-based nanocarriers for targeted cancer therapy","volume":"129","author":"Doroshenko","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijpx.2026.100638_bb0160","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/bjd\/ljad480","article-title":"Shifting landscape in skin cancer incidence: the rising tide of cutaneous squamous cell carcinoma and potential implications for prevention","volume":"190","author":"Eggermont","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124819","article-title":"Selective imaging, gene, and therapeutic delivery using PEGylated and pH-sensitive nanoparticles for enhanced lung disorder treatment","volume":"666","author":"Elsayed","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100638_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \u201cPEG dilemma\u201d in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/pcmr.12661","article-title":"Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and Therapeutic implications","volume":"31","author":"Fischer","year":"2017","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.ijpx.2026.100638_bb0180","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.addr.2012.01.020","article-title":"Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications","volume":"64","author":"Fleige","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100638_bb0185","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1021\/acsbiomaterials.5b00025","article-title":"Examples of tumor growth inhibition properties of liposomal formulations of pH-sensitive histidinylated cationic amphiphiles","volume":"1","author":"Garu","year":"2015","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ijpx.2026.100638_bb0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1471-2407-12-214","article-title":"Penetration of anticancer drugs through tumour tissue as a function of cellular packing density and interstitial fluid pressure and its modification by bortezomib","volume":"12","author":"Grantab","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijpx.2026.100638_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2022.1006628","article-title":"Localized topical drug delivery systems for skin cancer: current approaches and future prospects","volume":"4","author":"Gupta","year":"2022","journal-title":"Front. Nanotechnol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0200","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.7150\/jca.54699","article-title":"Dual role of reactive oxygen species and their application in cancer therapy","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.ijpx.2026.100638_bb0205","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41401-022-01011-4","article-title":"Comparison of two methods for tumour-targeting peptide modification of liposomes","volume":"44","author":"Huang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijpx.2026.100638_bb0210","article-title":"Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy","volume":"19","author":"Huang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0215","series-title":"Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes","first-page":"62","article-title":"Current update on the role of enhanced permeability and retention effect in cancer nanomedicine","author":"Jasim","year":"2017"},{"key":"10.1016\/j.ijpx.2026.100638_bb0220","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319880121","article-title":"Curvature-mediated rapid extravasation and penetration of nanoparticles against interstitial fluid pressure for improved drug delivery","volume":"121","author":"Jiang","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0225","first-page":"400","article-title":"Barrier-disrupting microneedle technology: overcoming physical, physiological, and pathological skin defenses to enhance therapeutic efficacy","volume":"57","author":"Jiang","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijpx.2026.100638_bb0230","doi-asserted-by":"crossref","first-page":"15313","DOI":"10.2147\/IJN.S535220","article-title":"New strategies in comprehensive melanoma treatment: applications, potential, and challenges of hydrogels","volume":"20","author":"Jin","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100638_bb0235","first-page":"1","article-title":"Oxidative stress in melanogenesis and melanoma development","volume":"26","author":"Kaminski","year":"2022","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0240","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/molecules27010146","article-title":"Smart nanocarriers as an emerging platform for cancer therapy: a review","volume":"27","author":"Kenchegowda","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijpx.2026.100638_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214636","article-title":"Enhanced permeability and retention (EPR) effect: advances in nanomedicine for improved tumor targeting","volume":"181","author":"Khan","year":"2026","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0250","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2020.09.040","article-title":"Dual-adjuvant effect of pH-sensitive liposomes loaded with STING and TLR9 agonists regress tumor development by enhancing Th1 immune response","volume":"328","author":"Kocabas","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100638_bb0255","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1039\/C8NH00417J","article-title":"DePEGylation strategies to increase cancer nanomedicine efficacy","volume":"4","author":"Kong","year":"2019","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.ijpx.2026.100638_bb0260","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/mp500108p","article-title":"MMP-9 responsive PEG cleavable nanovesicles for efficient delivery of chemotherapeutics to pancreatic cancer","volume":"11","author":"Kulkarni","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2026.100638_bb0265","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/10717544.2021.1905750","article-title":"pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0270","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.3390\/ijms25189779","article-title":"Charge-reversal nano-drug delivery systems in the tumor microenvironment: mechanisms, challenges, and therapeutic applications","volume":"25","author":"Liang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0275","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2147\/IJN.S461728","article-title":"Design and application of pH-responsive liposomes for site-specific delivery of cytotoxin from cobra venom","volume":"19","author":"Lin","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100638_bb0280","article-title":"Mechanistic investigation on oxidative degradation of ROS-responsive thioacetal\/thioketal moieties and their implications","volume":"1","author":"Liu","year":"2020","journal-title":"Cell Rep. Phys. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/CAD.0000000000000173","article-title":"Cytotoxic and anti-angiogenic paclitaxel solubilized and permeation-enhanced by natural product nanoparticles","volume":"26","author":"Liu","year":"2015","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ijpx.2026.100638_bb0290","article-title":"Reactive oxygen species-responsive polymer drug delivery systems","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0295","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1039\/D2NA00530A","article-title":"Functional nano-systems for transdermal drug delivery and skin therapy","volume":"5","author":"Liu","year":"2023","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0300","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.abb.2014.04.007","article-title":"Updates of reactive oxygen species in melanoma etiology and progression","volume":"0","author":"Liu-Smith","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijpx.2026.100638_bb0305","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpx.2026.100638_bb0310","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/pharmaceutics17030296","article-title":"Advances in materials science for precision melanoma therapy: nanotechnology-enhanced drug delivery systems","volume":"17","author":"Moni","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100638_bb0315","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2024.2372277","article-title":"Genistein transfersome-embedded topical delivery system for skin melanoma treatment: in vitro and ex vivo evaluations","volume":"31","author":"Motawea","year":"2024","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0320","series-title":"Histology, Stratum Corneum","author":"Murphrey","year":"2022"},{"issue":"5","key":"10.1016\/j.ijpx.2026.100638_bb0325","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1208\/s12249-024-02847-1","article-title":"Navigating skin delivery horizon: an innovative approach in pioneering surface modification of ultradeformable vesicles","volume":"25","author":"Nayak","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100638_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17050579","article-title":"Microneedles for melanoma therapy: exploring opportunities and challenges","volume":"17","author":"Nemakhavhani","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100638_bb0335","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1021\/acs.molpharmaceut.5c01130","article-title":"Triple-responsive cross-linked micelles for synergistic chemo-photothermal cancer therapy","volume":"22","author":"Ou","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2026.100638_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111223","article-title":"ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy","volume":"194","author":"Pan","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ijpx.2026.100638_bb0345","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/gels7040218","article-title":"Site-specific vesicular drug delivery system for skin cancer: a novel approach for targeting","volume":"7","author":"Pandey","year":"2021","journal-title":"Gels"},{"key":"10.1016\/j.ijpx.2026.100638_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107975","article-title":"Targeting cell adhesion molecules: Insight towards addressing targeted drug delivery in the inflammatory microenvironment","volume":"116","author":"Pandey","year":"2026","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217454","article-title":"Interrogation of the tumor microenvironment by nanoparticles","volume":"612","author":"Panja","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpx.2026.100638_bb0360","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.7150\/thno.37198","article-title":"Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100638_bb0365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s42004-025-01491-5","article-title":"Towards precision medicine using biochemically triggered cleavable conjugation","volume":"8","author":"Parshad","year":"2025","journal-title":"Commun. Chem."},{"key":"10.1016\/j.ijpx.2026.100638_bb0370","article-title":"Cancer cell membrane cloaked nanocarriers: a biomimetic approach towards cancer theranostics","volume":"33","author":"Patra","year":"2022","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.ijpx.2026.100638_bb0375","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13402-024-00969-z","article-title":"Acidity and hypoxia of tumor microenvironment, a positive interplay in extracellular vesicle release by tumor cells","volume":"48","author":"Peppicelli","year":"2024","journal-title":"Cell. Oncol."},{"issue":"8","key":"10.1016\/j.ijpx.2026.100638_bb0380","doi-asserted-by":"crossref","first-page":"13253","DOI":"10.1038\/s41598-018-31693-y","article-title":"Liposomes can both enhance or reduce drugs penetration through the skin","volume":"1","author":"Peralta","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100638_bb0385","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/cancers16132308","article-title":"Exploring extravasation in cancer patients","volume":"16","author":"Pham","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijpx.2026.100638_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.924553","article-title":"Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance","volume":"12","author":"Popovic","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0395","doi-asserted-by":"crossref","DOI":"10.34133\/research.0148","article-title":"Advanced strategies for overcoming endosomal\/lysosomal barrier in nanodrug delivery","volume":"6","author":"Qiu","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.ijpx.2026.100638_bb0400","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s13346-021-00909-6","article-title":"Enhancement strategies for transdermal drug delivery systems: current trends and applications","volume":"12","author":"Ramadon","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100638_bb0405","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/polym14040687","article-title":"Applications of the ROS-responsive thioketal linker for the production of smart nanomedicines","volume":"14","author":"Rinaldi","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijpx.2026.100638_bb0410","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.3390\/ijms22105283","article-title":"Influence of tumor microenvironment and fibroblast population plasticity on melanoma growth, therapy resistance and immunoescape","volume":"22","author":"Romano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0415","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12943-025-02456-x","article-title":"Microbiome-targeted nanoplatforms and engineering approaches in breast cancer therapy","volume":"24","author":"Sabeel","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijpx.2026.100638_bb0420","article-title":"Reactive-oxygen-species-responsive drug delivery systems: promises and challenges","volume":"4","author":"Saravanakumar","year":"2016","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0425","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1021\/acs.molpharmaceut.3c00126","article-title":"Natural ingredients of transdermal drug delivery systems as permeation enhancers of active substances through the stratum corneum","volume":"20","author":"Schafer","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2026.100638_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/jfb17010039","article-title":"Biomaterials for improving skin penetration in treatment of skin cancer","volume":"17","author":"Secci","year":"2026","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ijpx.2026.100638_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105474","article-title":"Quality by design enabled tumor microenvironment-responsive simvastatin-loaded liposomes for prostate cancer management","volume":"94","author":"Shahrukh","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0440","first-page":"445","article-title":"Enhancing drug penetration in solid tumors via nanomedicine: evaluation models, strategies and perspectives","volume":"32","author":"Shen","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ijpx.2026.100638_bb0445","doi-asserted-by":"crossref","DOI":"10.37349\/etat.2025.1002355","article-title":"Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response","volume":"6","author":"Singh","year":"2025","journal-title":"Explor. Target. Antitumor Ther."},{"key":"10.1016\/j.ijpx.2026.100638_bb0450","doi-asserted-by":"crossref","DOI":"10.1177\/15353508241257924","article-title":"PET\/CT in the evaluation of CAR-T cell immunotherapy in hematological malignancies","volume":"23","author":"Singh","year":"2024","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.ijpx.2026.100638_bb0455","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00249-021-01514-8","article-title":"Biophysical characterization of melanoma cell phenotype markers during metastatic progression","volume":"50","author":"Sobiepanek","year":"2021","journal-title":"Eur. Biophys. J."},{"key":"10.1016\/j.ijpx.2026.100638_bb0460","doi-asserted-by":"crossref","first-page":"16942","DOI":"10.1039\/D4NR01543F","article-title":"Vesicle\u2013micelle transitions driven by ROS, light and heat","volume":"16","author":"Subraveti","year":"2024","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100638_bb0465","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2026.100638_bb0470","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20240112","article-title":"Autophagy-targeting nanomedicine: strike at the heart of the cancer via precise modulation of autophagy","volume":"5","author":"Sun","year":"2025","journal-title":"Exploration"},{"key":"10.1016\/j.ijpx.2026.100638_bb0475","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10585-019-09990-1","article-title":"Adaptation to chronic acidic extracellular pH elicits a sustained increase in lung cancer cell invasion and metastasis","volume":"37","author":"Sutoo","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ijpx.2026.100638_bb0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413558","article-title":"Targeting matrix metalloproteinases and their inhibitors in melanoma","volume":"25","author":"Szczygielski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0485","first-page":"101","article-title":"ROS-responsive drug delivery systems for biomedical applications","volume":"13","author":"Tao","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125931","article-title":"Breaking barriers with pH-responsive nanocarriers: a new frontier in precision oncology","volume":"682","author":"Tapponi","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100638_bb0495","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1039\/C6CC02972H","article-title":"Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives","volume":"52","author":"Thambi","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijpx.2026.100638_bb0500","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jdin.2020.10.013","article-title":"The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990\u20132017","volume":"2","author":"Urban","year":"2021","journal-title":"JAAD Int."},{"key":"10.1016\/j.ijpx.2026.100638_bb0505","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/acs.biomac.1c01010","article-title":"Thioether-based polymeric micelles with fine-tuned oxidation sensitivities for chemotherapeutic drug delivery","volume":"23","author":"Van Der Vlies","year":"2021","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100638_bb0510","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s42114-024-01053-8","article-title":"A comprehensive review of conventional and stimuli-responsive delivery systems for bioactive peptides: from food to biomedical applications","volume":"8","author":"Wang","year":"2024","journal-title":"Adv. Compos. Hybrid Mater."},{"key":"10.1016\/j.ijpx.2026.100638_bb0515","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2147\/CCID.S569517","article-title":"Global burden of non-melanoma skin cancer among elder adults and projections to 2071: a systematic and comprehensive analysis of the Global Burden of Disease Study 2021","volume":"18","author":"Wang","year":"2025","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0520","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (EPR) effect: the significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ijpx.2026.100638_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202403563","article-title":"Antitumor cream: transdermal hydrogel containing liposome-encapsulated ruthenium complex for infrared-controlled multimodal synergistic therapy","volume":"14","author":"Yan","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2026.100638_bb0530","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3762\/bjnano.17.10","article-title":"From shield to spear: charge-reversible nanocarriers in overcoming cancer therapy barriers","volume":"17","author":"Yeduvaka","year":"2026","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0535","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s13346-024-01738-z","article-title":"Recent progress in topical and transdermal approaches for melanoma treatment","volume":"15","author":"Yourdkhani","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100638_bb0540","article-title":"Nanotechnology in skin cancer therapy: recent progress in targeted delivery","volume":"42","author":"Yu","year":"2025","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.ijpx.2026.100638_bb0545","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1038\/s41467-018-04910-5","article-title":"Water-dispersible PEG-curcumin\/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijpx.2026.100638_bb0550","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12951-021-01221-8","article-title":"Charge reversal nano-systems for tumor therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100638_bb0555","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3892\/mmr.2022.12819","article-title":"Role of ROS-mediated autophagy in melanoma","volume":"26","author":"Zhang","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ijpx.2026.100638_bb0560","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1021\/acsbiomaterials.4c01233","article-title":"ROS-responsive and self-catalytic nanocarriers for a combination of chemotherapy and reinforced ferroptosis against breast cancer","volume":"10","author":"Zhang","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.ijpx.2026.100638_bb0565","doi-asserted-by":"crossref","first-page":"49749","DOI":"10.1021\/acsomega.4c08267","article-title":"Magnetic nanocarriers for pH\/GSH\/NIR triple-responsive drug release and synergistic therapy in tumor cells","volume":"9","author":"Zhang","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijpx.2026.100638_bb0570","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.2147\/DDDT.S517331","article-title":"Stimuli-responsive drug delivery systems for enhanced melanoma immunotherapy","volume":"19","author":"Zhang","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijpx.2026.100638_bb0575","article-title":"A pH-responsive polymeric nanovaccine with efficient endosomal escape and potent antitumor immunity for cancer treatment","author":"Zhang","year":"2026","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2026.100638_bb0580","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/ph18071042","article-title":"Matrix metalloproteinase-2-responsive peptide-modified cleavable PEGylated liposomes for paclitaxel delivery","volume":"18","author":"Zhao","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpx.2026.100638_bb0585","article-title":"Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100638_bb0590","doi-asserted-by":"crossref","first-page":"319","DOI":"10.20892\/j.issn.2095-3941.2020.0496","article-title":"Stimuli-responsive nanocarriers for therapeutic applications in cancer","volume":"18","author":"Zhao","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ijpx.2026.100638_bb0595","article-title":"Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy","volume":"4","author":"Zheng","year":"2026","journal-title":"Pharm. Sci. Adv."},{"key":"10.1016\/j.ijpx.2026.100638_bb0600","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1021\/acs.molpharmaceut.5c00721","article-title":"Microneedle patches loaded with cRGD-modified pH-sensitive hydroxycamptothecin liposomes for melanoma therapy","volume":"22","author":"Zhou","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2026.100638_bb0605","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.3390\/molecules25235649","article-title":"pH-sensitive biomaterials for drug delivery","volume":"25","author":"Zhuo","year":"2020","journal-title":"Molecules"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:15:32Z","timestamp":1793031332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":121,"alternative-id":["S2590156726001581"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100638","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and therapeutic design of stimuli-responsive vesicular nanocarriers for melanoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100638"}}